Back to Trades
Sell4
Denali Therapeutics Inc.
DNLI
Total Value
$8.5M
Net $7.4M sold
Sales
$7.4M
1 transaction
Company Information
- Company Name
- Denali Therapeutics Inc.
- Ticker Symbol
- DNLI
- CIK
- 0001714899
Insider Information
- Name
- Watts Ryan J.
- Role
- President and CEO, Director
- Location
- SOUTH SAN FRANCISCO, CA
DirectorOfficer
Filing Details
- Filing Date
- Jul 11, 2025
- Transaction Date
- Jul 9, 2025
- Accession Number
- 0001714899-25-000149
- Form Type
- 4
- Net Trading Amount
- -$7.4M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 9, 2025 | Common Stock | 455,282 | $0.68 | Exercise | $309.6K |
| Jul 9, 2025 | Common Stock | 40,000 | $5.28 | Exercise | $211.2K |
| Jul 9, 2025 | Common Stock | 495,282 | $15.00 | Sale | $7.4M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 9, 2025 | Derivative | 455,282 | $0.68 | Exercise | $309.6K |
| Jul 9, 2025 | Derivative | 40,000 | $5.28 | Exercise | $211.2K |
Footnotes
- (F1)Includes 177,940 Unvested RSUs.
- (F2)The sales reported by the Reporting Person were made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 09/16/2024. The shares sold primarily relate to 455,282 stock options that expire on 08/21/2025.
- (F3)The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $15.00 to $15.08 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- (F4)The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.
- (F5)The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days.
- (F6)25% of the shares subject to the option will vest on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter.